The global Meningitis Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Meningitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningitis Vaccine.

Report Scope

The Meningitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Meningitis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Meningitis Vaccine Market Report

Report Metric	Details
Report Name	Meningitis Vaccine Market
CAGR	5%
Segment by Type	Meningitis A+C Meningitis ACWY135 Meningitis B
Segment by Application	Medical Care Hospital
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GlaxoSmithKline, Baxter International, Sanofi Pasteur, Merck, Novartis, Pfizer, Hualan, Zhejiang Tianyuan, Beijing Tiantan Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meningitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meningitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Meningitis Vaccine Market report?

Ans: The main players in the Meningitis Vaccine Market are GlaxoSmithKline, Baxter International, Sanofi Pasteur, Merck, Novartis, Pfizer, Hualan, Zhejiang Tianyuan, Beijing Tiantan Biological

What are the Application segmentation covered in the Meningitis Vaccine Market report?

Ans: The Applications covered in the Meningitis Vaccine Market report are Medical Care, Hospital

What are the Type segmentation covered in the Meningitis Vaccine Market report?

Ans: The Types covered in the Meningitis Vaccine Market report are Meningitis A+C, Meningitis ACWY135, Meningitis B

1 Meningitis Vaccine Market Overview

1.1 Product Overview and Scope of Meningitis Vaccine

1.2 Meningitis Vaccine Segment by Type

1.2.1 Global Meningitis Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Meningitis A+C

1.2.3 Meningitis ACWY135

1.2.4 Meningitis B

1.3 Meningitis Vaccine Segment by Application

1.3.1 Global Meningitis Vaccine Market Value by Application: (2024-2030)

1.3.2 Medical Care

1.3.3 Hospital

1.4 Global Meningitis Vaccine Market Size Estimates and Forecasts

1.4.1 Global Meningitis Vaccine Revenue 2019-2030

1.4.2 Global Meningitis Vaccine Sales 2019-2030

1.4.3 Global Meningitis Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Meningitis Vaccine Market Competition by Manufacturers

2.1 Global Meningitis Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Meningitis Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Meningitis Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Meningitis Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Meningitis Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Meningitis Vaccine, Product Type & Application

2.7 Meningitis Vaccine Market Competitive Situation and Trends

2.7.1 Meningitis Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Meningitis Vaccine Players Market Share by Revenue

2.7.3 Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Meningitis Vaccine Retrospective Market Scenario by Region

3.1 Global Meningitis Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Meningitis Vaccine Global Meningitis Vaccine Sales by Region: 2019-2030

3.2.1 Global Meningitis Vaccine Sales by Region: 2019-2024

3.2.2 Global Meningitis Vaccine Sales by Region: 2025-2030

3.3 Global Meningitis Vaccine Global Meningitis Vaccine Revenue by Region: 2019-2030

3.3.1 Global Meningitis Vaccine Revenue by Region: 2019-2024

3.3.2 Global Meningitis Vaccine Revenue by Region: 2025-2030

3.4 North America Meningitis Vaccine Market Facts & Figures by Country

3.4.1 North America Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Meningitis Vaccine Sales by Country (2019-2030)

3.4.3 North America Meningitis Vaccine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Meningitis Vaccine Market Facts & Figures by Country

3.5.1 Europe Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Meningitis Vaccine Sales by Country (2019-2030)

3.5.3 Europe Meningitis Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Meningitis Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Meningitis Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Meningitis Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Meningitis Vaccine Market Facts & Figures by Country

3.7.1 Latin America Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Meningitis Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Meningitis Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Meningitis Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Meningitis Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Meningitis Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Meningitis Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Meningitis Vaccine Sales by Type (2019-2030)

4.1.1 Global Meningitis Vaccine Sales by Type (2019-2024)

4.1.2 Global Meningitis Vaccine Sales by Type (2025-2030)

4.1.3 Global Meningitis Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Meningitis Vaccine Revenue by Type (2019-2030)

4.2.1 Global Meningitis Vaccine Revenue by Type (2019-2024)

4.2.2 Global Meningitis Vaccine Revenue by Type (2025-2030)

4.2.3 Global Meningitis Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Meningitis Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Meningitis Vaccine Sales by Application (2019-2030)

5.1.1 Global Meningitis Vaccine Sales by Application (2019-2024)

5.1.2 Global Meningitis Vaccine Sales by Application (2025-2030)

5.1.3 Global Meningitis Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Meningitis Vaccine Revenue by Application (2019-2030)

5.2.1 Global Meningitis Vaccine Revenue by Application (2019-2024)

5.2.2 Global Meningitis Vaccine Revenue by Application (2025-2030)

5.2.3 Global Meningitis Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Meningitis Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 GlaxoSmithKline

6.1.1 GlaxoSmithKline Corporation Information

6.1.2 GlaxoSmithKline Description and Business Overview

6.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 GlaxoSmithKline Meningitis Vaccine Product Portfolio

6.1.5 GlaxoSmithKline Recent Developments/Updates

6.2 Baxter International

6.2.1 Baxter International Corporation Information

6.2.2 Baxter International Description and Business Overview

6.2.3 Baxter International Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Baxter International Meningitis Vaccine Product Portfolio

6.2.5 Baxter International Recent Developments/Updates

6.3 Sanofi Pasteur

6.3.1 Sanofi Pasteur Corporation Information

6.3.2 Sanofi Pasteur Description and Business Overview

6.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Pasteur Meningitis Vaccine Product Portfolio

6.3.5 Sanofi Pasteur Recent Developments/Updates

6.4 Merck

6.4.1 Merck Corporation Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Merck Meningitis Vaccine Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Novartis

6.5.1 Novartis Corporation Information

6.5.2 Novartis Description and Business Overview

6.5.3 Novartis Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Novartis Meningitis Vaccine Product Portfolio

6.5.5 Novartis Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Pfizer Meningitis Vaccine Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Hualan

6.6.1 Hualan Corporation Information

6.6.2 Hualan Description and Business Overview

6.6.3 Hualan Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Hualan Meningitis Vaccine Product Portfolio

6.7.5 Hualan Recent Developments/Updates

6.8 Zhejiang Tianyuan

6.8.1 Zhejiang Tianyuan Corporation Information

6.8.2 Zhejiang Tianyuan Description and Business Overview

6.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Zhejiang Tianyuan Meningitis Vaccine Product Portfolio

6.8.5 Zhejiang Tianyuan Recent Developments/Updates

6.9 Beijing Tiantan Biological

6.9.1 Beijing Tiantan Biological Corporation Information

6.9.2 Beijing Tiantan Biological Description and Business Overview

6.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Beijing Tiantan Biological Meningitis Vaccine Product Portfolio

6.9.5 Beijing Tiantan Biological Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Meningitis Vaccine Industry Chain Analysis

7.2 Meningitis Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Meningitis Vaccine Production Mode & Process

7.4 Meningitis Vaccine Sales and Marketing

7.4.1 Meningitis Vaccine Sales Channels

7.4.2 Meningitis Vaccine Distributors

7.5 Meningitis Vaccine Customers

8 Meningitis Vaccine Market Dynamics

8.1 Meningitis Vaccine Industry Trends

8.2 Meningitis Vaccine Market Drivers

8.3 Meningitis Vaccine Market Challenges

8.4 Meningitis Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Beijing Tiantan Biological

List of Tables

Table 1. Global Meningitis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Meningitis Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Meningitis Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Meningitis Vaccine Sales (K MT) of Key Manufacturers (2019-2024)

Table 5. Global Meningitis Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Meningitis Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Meningitis Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Meningitis Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Meningitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Meningitis Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Meningitis Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Meningitis Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Meningitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningitis Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Meningitis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Meningitis Vaccine Sales by Region (2019-2024) & (K MT)

Table 18. Global Meningitis Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Meningitis Vaccine Sales by Region (2025-2030) & (K MT)

Table 20. Global Meningitis Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Meningitis Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Meningitis Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Meningitis Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Meningitis Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Meningitis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Meningitis Vaccine Sales by Country (2019-2024) & (K MT)

Table 27. North America Meningitis Vaccine Sales by Country (2025-2030) & (K MT)

Table 28. North America Meningitis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Meningitis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Meningitis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Meningitis Vaccine Sales by Country (2019-2024) & (K MT)

Table 32. Europe Meningitis Vaccine Sales by Country (2025-2030) & (K MT)

Table 33. Europe Meningitis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Meningitis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Meningitis Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Meningitis Vaccine Sales by Region (2019-2024) & (K MT)

Table 37. Asia Pacific Meningitis Vaccine Sales by Region (2025-2030) & (K MT)

Table 38. Asia Pacific Meningitis Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Meningitis Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Meningitis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Meningitis Vaccine Sales by Country (2019-2024) & (K MT)

Table 42. Latin America Meningitis Vaccine Sales by Country (2025-2030) & (K MT)

Table 43. Latin America Meningitis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Meningitis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Meningitis Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Meningitis Vaccine Sales by Country (2019-2024) & (K MT)

Table 47. Middle East & Africa Meningitis Vaccine Sales by Country (2025-2030) & (K MT)

Table 48. Middle East & Africa Meningitis Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Meningitis Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Meningitis Vaccine Sales (K MT) by Type (2019-2024)

Table 51. Global Meningitis Vaccine Sales (K MT) by Type (2025-2030)

Table 52. Global Meningitis Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Meningitis Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Meningitis Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Meningitis Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Meningitis Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Meningitis Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Meningitis Vaccine Price (USD/MT) by Type (2019-2024)

Table 59. Global Meningitis Vaccine Price (USD/MT) by Type (2025-2030)

Table 60. Global Meningitis Vaccine Sales (K MT) by Application (2019-2024)

Table 61. Global Meningitis Vaccine Sales (K MT) by Application (2025-2030)

Table 62. Global Meningitis Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Meningitis Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Meningitis Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Meningitis Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Meningitis Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Meningitis Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Meningitis Vaccine Price (USD/MT) by Application (2019-2024)

Table 69. Global Meningitis Vaccine Price (USD/MT) by Application (2025-2030)

Table 70. GlaxoSmithKline Corporation Information

Table 71. GlaxoSmithKline Description and Business Overview

Table 72. GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. GlaxoSmithKline Meningitis Vaccine Product

Table 74. GlaxoSmithKline Recent Developments/Updates

Table 75. Baxter International Corporation Information

Table 76. Baxter International Description and Business Overview

Table 77. Baxter International Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. Baxter International Meningitis Vaccine Product

Table 79. Baxter International Recent Developments/Updates

Table 80. Sanofi Pasteur Corporation Information

Table 81. Sanofi Pasteur Description and Business Overview

Table 82. Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. Sanofi Pasteur Meningitis Vaccine Product

Table 84. Sanofi Pasteur Recent Developments/Updates

Table 85. Merck Corporation Information

Table 86. Merck Description and Business Overview

Table 87. Merck Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Merck Meningitis Vaccine Product

Table 89. Merck Recent Developments/Updates

Table 90. Novartis Corporation Information

Table 91. Novartis Description and Business Overview

Table 92. Novartis Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. Novartis Meningitis Vaccine Product

Table 94. Novartis Recent Developments/Updates

Table 95. Pfizer Corporation Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 98. Pfizer Meningitis Vaccine Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Hualan Corporation Information

Table 101. Hualan Description and Business Overview

Table 102. Hualan Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 103. Hualan Meningitis Vaccine Product

Table 104. Hualan Recent Developments/Updates

Table 105. Zhejiang Tianyuan Corporation Information

Table 106. Zhejiang Tianyuan Description and Business Overview

Table 107. Zhejiang Tianyuan Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 108. Zhejiang Tianyuan Meningitis Vaccine Product

Table 109. Zhejiang Tianyuan Recent Developments/Updates

Table 110. Beijing Tiantan Biological Corporation Information

Table 111. Beijing Tiantan Biological Description and Business Overview

Table 112. Beijing Tiantan Biological Meningitis Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 113. Beijing Tiantan Biological Meningitis Vaccine Product

Table 114. Beijing Tiantan Biological Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Meningitis Vaccine Distributors List

Table 118. Meningitis Vaccine Customers List

Table 119. Meningitis Vaccine Market Trends

Table 120. Meningitis Vaccine Market Drivers

Table 121. Meningitis Vaccine Market Challenges

Table 122. Meningitis Vaccine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Meningitis Vaccine

Figure 2. Global Meningitis Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Meningitis Vaccine Market Share by Type in 2023 & 2030

Figure 4. Meningitis A+C Product Picture

Figure 5. Meningitis ACWY135 Product Picture

Figure 6. Meningitis B Product Picture

Figure 7. Global Meningitis Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Meningitis Vaccine Market Share by Application in 2023 & 2030

Figure 9. Medical Care

Figure 10. Hospital

Figure 11. Global Meningitis Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Meningitis Vaccine Market Size (2019-2030) & (US$ Million)

Figure 13. Global Meningitis Vaccine Sales (2019-2030) & (K MT)

Figure 14. Global Meningitis Vaccine Average Price (USD/MT) & (2019-2030)

Figure 15. Meningitis Vaccine Report Years Considered

Figure 16. Meningitis Vaccine Sales Share by Manufacturers in 2023

Figure 17. Global Meningitis Vaccine Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Meningitis Vaccine Players: Market Share by Revenue in 2023

Figure 19. Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Meningitis Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Meningitis Vaccine Sales Market Share by Country (2019-2030)

Figure 22. North America Meningitis Vaccine Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Meningitis Vaccine Sales Market Share by Country (2019-2030)

Figure 26. Europe Meningitis Vaccine Revenue Market Share by Country (2019-2030)

Figure 27. Germany Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Meningitis Vaccine Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Meningitis Vaccine Revenue Market Share by Region (2019-2030)

Figure 34. China Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Meningitis Vaccine Sales Market Share by Country (2019-2030)

Figure 45. Latin America Meningitis Vaccine Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Meningitis Vaccine Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Meningitis Vaccine Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Meningitis Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Meningitis Vaccine by Type (2019-2030)

Figure 55. Global Revenue Market Share of Meningitis Vaccine by Type (2019-2030)

Figure 56. Global Meningitis Vaccine Price (USD/MT) by Type (2019-2030)

Figure 57. Global Sales Market Share of Meningitis Vaccine by Application (2019-2030)

Figure 58. Global Revenue Market Share of Meningitis Vaccine by Application (2019-2030)

Figure 59. Global Meningitis Vaccine Price (USD/MT) by Application (2019-2030)

Figure 60. Meningitis Vaccine Value Chain

Figure 61. Meningitis Vaccine Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions